A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
通過四位分析師的專家觀點，深入了解health catalyst。
In the last three months, 4 analysts have published ratings on Health Catalyst (NASDAQ:HCAT), offering a diverse range of perspectives from bullish to bearish.
過去三個月，有4位分析師對Health Catalyst (NASDAQ:HCAT) 發佈了評級，從看好到看淡不一。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $11.5, a high estimate of $14.00, and a low estimate of $8.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 6.12%.
分析師們爲Health Catalyst設定了12個月的價格目標，平均目標爲11.5美元，最高估值爲14.00美元，最低估值爲8.00美元。隨着分析師將平均目標價下調6.12%，情緒的負向轉移顯而易見。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
In examining recent analyst actions, we gain...
通過分析最近分...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。